Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma

October 25, 2022 | Comments Off on Define the Two Molecular Subtypes of Epithelioid Malignant Pleural Mesothelioma

Cells 2022 September 19 [Link] Umair Ali Khan Saddozai, Fengling Wang, Saadullah Khattak, Muhammad Usman Akbar, Muhammad Badar, Nazeer Hussain Khan, Lu Zhang, Wan Zhu, Longxiang Xie, Yongqiang Li, Xinying…

Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma

October 24, 2022 | Comments Off on Incidence and Risk Factors of Chest Wall Metastasis at Biopsy Sites in Patients with Malignant Pleural Mesothelioma

Cancers 2022 September 7 [Link] Masaki Hashimoto, Michiko Yuki, Kazuhiro Kitajima, Akihiro Fukuda, Toru Nakamichi, Akifumi Nakamura, Ayumi Kuroda, Seiji Matsumoto, Nobuyuki Kondo, Ayuko Sato, Koichiro Yamakado, Tohru Tsujimura, Seiki…

Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma

October 14, 2022 | Comments Off on Systematic Review, Meta-Analysis and Bioinformatic Analysis of Biomarkers for Prognosis of Malignant Pleural Mesothelioma

Diagnostics 2022 September 12 [Link] Zhenhua Lu, Wenlong Zhang, Ke Huang, Mucheng Zhu, Xiaoting Gu, Defang Wei, Mingxuan Shi, Yaqiong Chen , Huihui Wang Abstract In previous studies, non-invasive diagnostic…

Cytoreductive Surgical Treatment of Pleural Mesothelioma in a Porcine Model Using Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) and Radiofrequency Ablation (RFA)

October 13, 2022 | Comments Off on Cytoreductive Surgical Treatment of Pleural Mesothelioma in a Porcine Model Using Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) and Radiofrequency Ablation (RFA)

Tomography 2022 September 3 [Link] Marcia Costa, Carolina Fernandes, Matt Eames, Arik Hananel , John P Mugler 3rd, Jhosep Huaromo, Jack B Yang, Jaime Mata Abstract A combination of surgery…

Genomic landscape of pleural and peritoneal mesothelioma tumours

October 12, 2022 | Comments Off on Genomic landscape of pleural and peritoneal mesothelioma tumours

British Journal of Cancer 2022 September 22 [Link] Stefanie Hiltbrunner, Zoe Fleischmann, Ethan S Sokol, Martin Zoche , Emanuela Felley-Bosco , Alessandra Curioni-Fontecedro Abstract Background: Malignant pleural and peritoneal mesotheliomas…

Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?

October 11, 2022 | Comments Off on Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab?

Lung Cancer 2022 September 5 [Link] Maria J Disselhorst, Yoni Lubeck, Vincent van der Noort, Josine Quispel-Janssen, Iris M Seignette, Joyce Sanders , Dennis Peters, Erik Hooijberg, Paul Baas Abstract…

Expression of phosphorylated ribosomal protein S6 in mesothelioma patients – correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

October 10, 2022 | Comments Off on Expression of phosphorylated ribosomal protein S6 in mesothelioma patients – correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project

Modern Pathology 2022 September 17 [Link] Jan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, Kristiaan Nackaerts, Marc de Perrot, Luka Brcic, Ernest Nadal, Sotirios Tsimpoukis, Steven G Gray, Luca Ampollini, Joachim…

Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy

October 7, 2022 | Comments Off on Effects of tumor-infiltrating CD8+ T cells, PD1/PD-L1 axis, and expression patterns of HLA class I on the prognosis of patients with malignant pleural mesothelioma who underwent extra-pleural pneumonectomy

Cancer Immunology, Immunotherapy 2022 September 17 [Link] Riki Okita, Yuka Mimura-Kimura, Nobutaka Kawamoto, Naoki Yamamoto, Masashi Umeda, Masanori Okada, Hidetoshi Inokawa, Yusuke Mimura, Tomoyuki Murakami, Masao Nakata, Kazunori Okabe Abstract…

Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma

October 6, 2022 | Comments Off on Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma

International Journal of Cancer 2022 September 14 [Link] Mandy van Gulijk, Bob Belderbos, Daphne Dumoulin, Robin Cornelissen, Koen Bezemer, Larissa Klaase, Floris Dammeijer, Joachim Aerts Abstract Immunotherapy with anti-PD1/PD-L1 is…

BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation

October 5, 2022 | Comments Off on BMP and activin membrane-bound inhibitor regulate connective tissue growth factor controlling mesothelioma cell proliferation

BMC Cancer 2022 September 15 [Link] Nguyen Truong Duc Hoang, Ghmkin Hassan, Tomoya Suehiro, Yuichi Mine, Tohru Matsuki, Makiko Fujii Abstract Background: Malignant mesothelioma (MM) is an aggressive mesothelial cell…

Categories